Unichem Laboratories Limited share price
NSE: UNICHEMLAB · ISIN INE351A01035
Key numbers
- Market cap
- ₹ 3,870 Cr
- Current price
- ₹ 549.70
- 52-week high / low
- ₹ 687 / 278
- Stock P/E
- 13.2
- Book value
- ₹ 386.0
- Dividend yield
- 0.00%
- ROCE
- 10.6%
- ROE
- 9.8%
- Debt to equity
- 0.18
- Sales growth (3 yrs)
- 18.4%
- Profit growth (3 yrs)
- -
- 1-year return
- 12.0%
About Unichem Laboratories Limited
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, formulations, bulk drugs, and chemicals. It serves distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 527 | 579 | 521 | 575 | 633 |
| Operating profit | 22 | 66 | 45 | 48 | 70 |
| Net profit | -10 | -12 | 264 | 11 | 41 |
| EPS (₹) | -1.49 | -1.69 | 37.54 | 1.55 | 5.89 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.